Jiangsu Recbio Technology Co., Ltd. announced that due to job changes, Mr. Gu Zhongcai (Mr. Gu) and Ms. Wang Hongyang (Ms. Wang) have tendered their resignations as supervisors of the first session of the board of supervisors of the Company (the Supervisory Board) on June 30, 2022. Ms. Wang's resignation will take effect from June 30, 2022 while Mr. Gu's resignation will take effect upon the completion of the amendments to the Articles of Association of the Company. Prior to that, Mr. Gu will continue to perform his duties as a supervisor.

Mr. Gu and Ms. Wang have confirmed that they have no disagreement with the Company, the Board and the Supervisory Board and there are no other matters relating to their resignation that need to be brought to the attention of the Hong Kong Stock Exchange and the Shareholders. Ms. Liu Ping, aged 43, served as the QA director of Gan & Lee Pharmaceutical Co., Ltd.) (the predecessor of Gan & Lee Pharmaceutical Holdings Ltd.) from January 2002 to August 2010, director of the quality department of Beijing Mabworks Biotech Co., Ltd. from September 2010 to April 2011, manager of the quality department of Beijing ABZYMO Biosciences Co., Ltd. from May 2011 to October 2019, and has served as deputy manager of the comprehensive management department of the Company since November 2019. Ms. Liu graduated from Shenyang Pharmaceutical University in 2001, and from the Network School of Medical Education of Peking University in 2015, both majoring in pharmacy.

Ms. Liu shall jointly form the first session of the Supervisory Board of the Company with other members of the first session of the Supervisory Board, with a term of office commencing from June 30, 2022 and ending on the expiry of the term of the first session of the Supervisory Board, and shall be eligible for re-election upon expiry of the term. The Company will enter into a supervisor's service contract with Ms. Liu. During the term of office, except as otherwise provided in the remuneration scheme for supervisors of the Company, Ms. Liu shall not receive any remuneration as a supervisor from the Company but will continue to receive remuneration as an employee.